Injective price prediction: Can $4.90 resistance contain INJ uptrend?

Traders Union
All News
Crypto
Injective rises 7.41% to $3.74 today

Highlights

INJ trades with strong short- and medium-term bullish momentum but faces longer-term resistance from the 200-day trend.
Technical indicators confirm persistent buyer pressure intraday, though oscillators signal short-term overbought conditions and trend weakness.
INJ is expected to consolidate between $3.50 and $3.95, with downside more likely unless it breaks above resistance.

Mixed momentum limits upside despite overbought technicals

On the technical front, INJ is trading well above both its 20-day SMA at $3.16 and its 50-day SMA at $3.05, while it remains below the 200-day SMA at $4.90, highlighting sustained longer-term resistance. The Ichimoku Kijun level at $3.20 provides immediate support. Momentum indicators are mixed: while the daily MACD and RSI remain bullish, the low ADX reading of 13.25 points to weak trend strength, and both Stoch RSI and CCI reveal overbought conditions that could limit further upside in the short term. The BBP at 0.38 shows that buyers dominate intraday action, further supported by a bullish Awesome Oscillator reading.

Downside risk favored as weekly signals remain bearish

Looking to the week ahead, INJ is expected to fluctuate within a $3.50 to $3.95 range, a typical volatility band relative to current levels. The probability of a sustained price increase is considered low, while downside movement remains more likely due to persistent weekly bearish signals in major indicators. The base case anticipates continued consolidation between key support and resistance levels. Should a bullish breakout above $3.95 occur, a move toward higher resistance zones is possible, whereas a bearish break below $3.50 could accelerate declines toward lower technical support.

Anton Kharitonov, expert at Traders Union, sees INJ in a technical uptrend, but notes that longer-term resistance remains significant. He is cautious as weak trend strength and overbought signals limit upside potential. The base scenario is continued consolidation between $3.50 and $3.95, with a bearish resolution more likely unless resistance is convincingly broken. "Until INJ decisively clears $3.95, I would stay cautious and focus on risk management."

Earlier, analysts noted that Injective was showing short-term recovery signals but remained weighed down by prevailing medium- and long-term bearish momentum. The latest technicals reinforce this cautious stance, suggesting traders should monitor for a potential reversal if downside pressure intensifies below $3.50 in the coming sessions.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.